Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
11 July 2022 | Story Andre Damons | Photo Supplied
Prof Martie Smith and Prof Drik Opperman
Prof Martie Smit and Prof Dirk Opperman in the Department of Microbiology and Biochemistry filed a patent entitled “Process for the chemical modification of alkanes, fatty acids and fatty alcohols”.

Flavours and fragrances have a wide application in the food, feed, cosmetic, chemical and pharmaceutical sectors. Many flavour compounds are still produced via chemical synthesis or via extraction from plant or animal sources. However, there is increasing interest in their bio-production or the use of flavour compounds of (micro) biological origin. 

One reason for this shift is that chemical synthesis often uses environmentally unfriendly processes. Chemical synthesis usually also produces racemic mixtures with the second enantiomer, mirror image of the looked-for compound, often having undesirable organoleptic properties. Furthermore, the consumer has developed a “chemophobia”-attitude towards synthetic chemical compounds, especially when related to food and home-care products.  This applies even to nature-identical compounds – products that occur in nature but are produced via a non-natural chemical process. Products produced with the use of enzymes or microbes from “natural” substrates can be labelled “natural”. The flavour and fragrance industry thus pay higher prices for such products labelled as “natural”.  

The invention

A University of the Free State (UFS) team, led by Prof Martie Smit and Prof Dirk Opperman in the Department of Microbiology and Biochemistry are conducting exciting research in this area. They filed a patent entitled “Process for the chemical modification of alkanes, fatty acids and fatty alcohols”.  

The invention relates to a process for the enzymatic in-chain hydroxylation of C12 to C16 fatty acids, alcohols, and alkanes. Hydroxylation of C12 fatty acid and alcohol provides routes for the synthesis of “natural” δ-dodecalactone. The advantage of these routes is that they do not rely on massoia lactones. Massoia lactones are derived from the bark of Massoia trees which grow in Indonesia. Harvesting of the bark kills the trees.  

The cytochrome P450 enzymes (P450s) claimed in this patent are to the inventors’ knowledge the most regioselective enzymes described thus far that can be used for the synthesis of δ-dodecalactone from lauric acid or 1-dodecanol. The approach that the technology takes is to claim cytochrome P450 enzymes that share 70 % amino acid identity to a set of selected P450s for the regioselective hydroxylation of lauric acid and 1-dodecanol to synthesise δ-dodecalactone.

Still in early stage

The current state of development is early stage with the technology only demonstrated in the laboratory on a small scale (100-200 ml). Before the technology can be commercialised the team would need to further improve the regioselectivity and stability of the P450s and proof that the reactions can be scaled up in bioreactors. The technology will probably be delivered as an enzyme (amino acid sequence) with the desired properties. 

There are other research groups working on a synthetic biology approach for the de novo synthesis of δ-dodecalactone from glucose by genetically engineered microbes. It is still unclear how such a process will compare in terms of product yields, economics and environmental impact with the processes proposed by the UFS patent.

If the team had to partner with a commercial company, their first choice would be to work with an established flavour and fragrance company. Another possibility would be the small French flavour and fragrance company that Dr Alizé Pennec, the post-doc and co-inventor who initially discovered the unique P450 activity, is working for.

Please view the videos for more information on patents.

The Vice-Rector: Research and Internationalisation has released two new calls for applications for funding. Academic staff and researchers are encouraged to submit applications for these funds. At this stage we are not accepting projects from Research Fellows. 

The two funds are: 

1.  The Industrial Engagement Fund 
2.  The Intellectual Property Commercialisation Fund

Each fund has its own guidelines and application process. The guidelines are attached. The applications must be filled in on RIMS.

The RIMS application forms can be found through this link

For more information please click the documents below:



News Archive

Quadriplegic doctor obtains degree against all odds
2016-11-25

Description: Dr Swartbooi CUADS Tags: Dr Swartbooi CUADS

Dr Swartbooi faces each day with vigour and
resilience. Dr Swartbooi analyses images on
a screen in the Clinical Imaging Laboratory
at Universitas Academic Hospital.

Photo: Oteng Mpete

Life’s defining moments are when perseverance is rewarded. It is not easy to swim against the tide. However, for Dr Ambrotius Swartbooi from the University of the Free State’s Department of Clinical Imaging Sciences, it became his moment of glory. In 2006, Dr Swartbooi suffered a spinal injury from a near-fatal car accident which left him paralysed and a quadriplegic.

The strength to carry on

“You have one of two choices:
to lie down and give up,
or to pick yourself up”
—Dr Swartbooi

Dr Swartbooi spent close to six months, recovering from his injuries. “You have one of two choices: to lie down and give up or to pick yourself up,” said Dr Swartbooi. He would inspire other patients with similar injuries to reintegrate into society despite their new-found circumstances.

Fortunately, not all was doom and gloom; in 2007 Dr Swartbooi got married, and his wife has supported and inspired him to continue pursuing his dreams. Dr Swartbooi completed his undergraduate medical degree at the UFS, and in 2014 decided it was time to complete his studies and pursued an MMed specialising in Diagnostic Radiology.

To treat or not treat: that is the question

After all his trials and tribulations, Dr Swartbooi will be receiving his MMed Diagnostic Radiology degree at the UFS Summer Graduation ceremony in December 2016. His research focuses on intracranial aneurysm size interventions. He discovered that there were discrepancies between international standards for intervention and African standards for intervention.

The research inspects what should be treated and how it should be treated. He found there was a gap in African literature into the size of aneurysms.

Champion of survival: Where to from here?

“That’s a good question,” said Dr Swartbooi. “Slowly from here. I still need to work on getting my full accreditation from the Health Professions Council of South Africa (HPCSA).” He plans to continue fuelling his passion for teaching. “There is no place better to teach than at an academic hospital.”

Dr Swartbooi commended the efforts of the Centre for Universal Access and Disability Support (CUADS), which assisted him in writing all his exams. “I want to be able to make a fulfilling and lasting impact on people but also to give the best medical service that I can,” concluded Dr Swartbooi.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept